DG

Investment firm

Debiopharm Group

Corporate VC

LinkedIn pageX profileCrunchbase profileLausanne·Switzerland17known portfolio companies3people tracked20co-investors

Debiopharm Group is a corporate venture arm. Team members are concentrated in Lausanne, Vaud, Switzerland. The known portfolio counts 17 companies, including StratifAI, ViewsML, Concr, Raidium, ModernVivo and Tune Insight.

Is Debiopharm Group a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Contacts

inf***@***.comAvailable after registration.
Get contact

Who to pitch at Debiopharm Group

Debiopharm Group portfolio companies (17)

  • StratifAI
  • ViewsML
  • Concr
  • Raidium
  • ModernVivo
  • Tune Insight
  • Immunexpress
  • MedaSystems
  • Coorpacademy
  • GenePOC
  • Little Green House
  • Neuroute
  • Novadiscovery
  • Octozi
  • OmicsChart
  • Risklick
  • WhiteLab Genomics

Co-investors

Funds that share portfolio companies with Debiopharm Group.

Similar funds

Showing 20 of 100

About Debiopharm Group

The firm's listing covers sectors AI and Healthcare, and focus areas Analytics, Biotech, Clinical Trials and Diagnostics; known deals cluster at Pre-Seed, Seed and Series A.

Vincent Lepreux (Principal), Marc Cikes (Affiliated) and Sara Picó (Affiliated) are listed as the contacts to pitch at Debiopharm Group.

Across the known portfolio, 20 co-investors appear alongside Debiopharm Group, including Heliad, Illumina and Alven.

Frequently asked questions

What is Debiopharm Group?

Debiopharm Group is a corporate venture arm whose team is concentrated in Lausanne, Vaud, Switzerland, with a known portfolio of 17 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.

What does Debiopharm Group invest in?

Listed sectors include AI and Healthcare; listed focus areas include Analytics, Biotech, Clinical Trials and Diagnostics. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.

What stage does Debiopharm Group invest at?

The known deals of Debiopharm Group include Pre-Seed, Seed and Series A rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.

Who should I pitch at Debiopharm Group?

All 3 people on file at Debiopharm Group are listed as contacts for the firm, each with their own profile page.

How do I contact Debiopharm Group?

Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 3 people attached to the firm have their own pages, each showing whether an address is on file for them.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal